Home   |   Contact Us

E-Mail Sign-up

Stay up-to-date with critical immunization for women topics by signing up for our
e-mail updates and alert notifications.


Help Spread the Word

Share this important information to friends, family and colleagues with just a few clicks!

Share |


Two-dimensional barcodes could make it easier to collect and document immunization information in patients' records. These barcodes could contain the manufacturer, product, expiration date, and lot number information needed for immunization records. Although manufacturers aren't placing them on vaccines yet, these barcodes could improve patient safety and record keeping. Through a contract with the Centers for Disease Control and Prevention, RTI International is conducting a 10-minute Vaccine Barcoding Survey to learn more about the impact that including these barcodes on vaccines would have on providers like you. Please help CDC explore the benefits and costs of using two-dimensional barcodes by telling CDC how you think it could affect your immunization practice. Click here to take the survey.  You can enter a raffle to win 1 of 10 iPads as a thank you for sharing your perspective!*

*You will need to know how many doses of childhood, adolescent, adult, travelers', and influenza vaccines you give per year before starting the survey. This information will improve CDC's ability to understand responses they receive, but if this information is not available, please complete the rest of the survey. A sample survey is available for download from the website. All responses are confidential and will only be used to inform CDC's vaccine barcoding study. For questions and comments, contact barcodingsurvey@rti.org.

Vaccines and Medications in Pregnancy Surveillance System (VAMPSS) is a new joint effort of government, medical specialists, and leading independent research institutions to study the safety of vaccines during pregnancy and medicines taken during pregnancy.  Pregnant women who have received influenza vaccine or influenza antivirals or who are taking asthma medications are encouraged to enroll themselves so they can be followed during their pregnancy and the postpartum period by calling (877) 311-8972. Clinicians can refer pregnant patients to learn about this new effort. For more information on enrolling patients visit http://www.otispregnancy.org/vaccines.


Visit The American College of Obstetricians and Gynecologists Website

© Copyright 2012 The American College of Obstetricians and Gynecologists   |   Contact Us   |   Disclaimers